$NERX PONIARD PHARMACEUTICALS, INC. Insider Trading
Get free email notifications about insider trading in PONIARD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PONIARD PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in PONIARD PHARMACEUTICALS, INC. for free.
CIK Number: 0000755806
IRS Number: 911261311
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NERX
Company Address: 300 ELLIOTT AVENUE WEST SUITE 530 SEATTLE 98119-4114
Former name: NEORX CORP, date of change: 1992-07-03
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
PONIARD PHARMACEUTICALS, INC. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 27 2012 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Sell | S | 0.83 | 1,599 | 1,330 | 8,920 | 10.5 K to 8.9 K (-15.20 %) |
Mar 27 2012 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Option Exercise | M | 0.00 | 2,800 | 0 | 0 | |
Mar 27 2012 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Buy | M | 0.00 | 2,800 | 0 | 10,519 | 7.7 K to 10.5 K (+36.27 %) |
Mar 27 2012 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Sell | S | 0.83 | 257 | 214 | 5,668 | 5.9 K to 5.7 K (-4.34 %) |
Feb 17 2012 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Sell | S | 0.87 | 2,401 | 2,084 | 5,450 | 7.9 K to 5.5 K (-30.58 %) |
Mar 27 2012 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Option Exercise | M | 0.00 | 475 | 0 | 0 | |
Mar 27 2012 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Buy | M | 0.00 | 475 | 0 | 5,925 | 5.5 K to 5.9 K (+8.72 %) |
Feb 17 2012 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Sell | S | 0.87 | 6,346 | 5,508 | 7,719 | 14.1 K to 7.7 K (-45.12 %) |
Feb 17 2012 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Option Exercise | M | 0.00 | 12,019 | 0 | 0 | |
Feb 17 2012 | NERX | PONIARD PHARMACEUT ... | PERRY MICHAEL S | President & CMO | Buy | M | 0.00 | 12,019 | 0 | 14,065 | 2 K to 14.1 K (+587.44 %) |
Feb 17 2012 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Option Exercise | M | 0.00 | 5,769 | 0 | 0 | |
Feb 17 2012 | NERX | PONIARD PHARMACEUT ... | JACKSON MICHAEL K | Interim CFO | Buy | M | 0.00 | 5,769 | 0 | 7,851 | 2.1 K to 7.9 K (+277.09 %) |
Oct 07 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Option Exercise | M | 0.00 | 25,000 | 0 | 50,000 | |
Oct 07 2011 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Chief Executive Off ... | Buy | M | 0.00 | 25,000 | 0 | 548,073 | 523.1 K to 548.1 K (+4.78 %) |
Jul 12 2011 | NERX | PONIARD PHARMACEUT ... | LYONS GARY A | Director | Option Exercise | M | 0.00 | 85,000 | 0 | 0 |
View all PONIARD PHARMACEUTICALS, INC. insider transactions.